Organization
Versartis
2 clinical trials
Clinical trial
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone DeficiencyStatus: Completed, Estimated PCD: 2017-08-23
Clinical trial
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)Status: Terminated, Estimated PCD: 2018-01-11